Mylan Launches Generic Antara® Capsules
Mylan Inc. (Nasdaq:MYL) today announced that its subsidiary Mylan Pharmaceuticals has begun shipping Fenofibrate Capsules USP, 43 mg and 130 mg. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - February 26, 2013 Category: Pharmaceuticals Source Type: news